Mohs surgery, developed by a dermatologist named Fredrick Mohs, has become the gold standard for treating skin cancers such as basal and squamous cell carcinomas. Typically employed for difficult-to-treat cancers, Mohs surgery involves removing the visible tumor along with thin layers of skin underneath. A dermatopathologist then examines these removed layers for the presence of cancerous cells. This process, known as mapping, enables a surgeon to pinpoint and remove the areas of cancerous tissue until they can no longer detect any cells. This procedure has several advantages over conventional skin cancer treatments, as it offers a higher rate of cure rate and avoids unnecessary removal of healthy tissue. Additionally, because it carefully targets cancerous cells, it can help to preserve the surrounding healthy tissue which minimizes scarring and ensures that the best cosmetic outcome is achieved. During the day or surgery, the patient is awake and is numbed with local anesthetic. The whole process can usually be finished within three hours. Initially, the area of skin cancer is marked and the surrounding tissue is numbed. A curette (small spoon-shaped instrument) is then used to remove visible tumor, and a map is used to indicate the underlying tissue layers. The removed tissue is examined under a microscope to see if cancer is still present. If it is, the map is noted and another layer of tissue is removed. This cycle will continue until all cancer cells are removed. In summary, Mohs surgery is a precise, safe and effective technique for treating skin cancer and is increasingly being used since it offers the highest cure rates for these kinds of cancer. Furthermore, it minimizes the chance of scarring or other complications as only the layer of skin containing the cancer cells is removed.
Title : Integrating personalized and precision medicine into dermatology clinical practice securing ITS potential to get skin diseases cured and to revolutionize dermatology
Sergey Suchkov, National Center for Human Photosynthesis, Mexico
Title : Global perspectives on skin health: Diversity in dermatology and cosmetology
Dave Ray, Dave Ray Enterprises., United States
Title : How to correct cosmetic procedures gone wrong
Bharti Magoo, Golden Touch Clinic, India
Title : Epitomic analysis revealed pemphigus autoantibodies against the ligand-binding pocket of M3 muscarinic acetylcholine receptor
Sergei A Grando, University of California Irvine, United States
Title : Perspectives on healthy skin aging and pre-aging concepts
Georgios Stamatas, SGS France, France
Title : Efficacy and safety of rituximab versus pulse therapy in immunobullous disorders: A retrospective study
Ravi M Rathod, KMCRI, India
Title : Dermatology and cosmetology through art and history of art
Dechelette Corinne, La Peau Autrement, France
Title : Acne vulgaris and the most popular and new cosmetological treatments
Karolina Chilicka Hebel, University of Opole, Poland
Title : Stem cells in dermatology and cosmetology
Makoto Senoo, Cell Exosome Therapeutics Inc, Japan
Title : Standards, education and application of special cosmetic treatments in cosmetology practice
Elizabeta Popova Ramova, University MIT Skopje, Macedonia, The Former Yugoslav Republic of